Neurotoxic effects and biomarkers of lead exposure: A review

Reviews on Environmental Health

Volumn 24, Issue 1, 2009, Pages 15-45

  Sanders, Talia ^a   Liu, Yiming ^a   Buchner, Virginia ^b   Tchounwou, Paul B ^a  

^a JACKSON STATE UNIVERSITY   (United States)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Biological monitoring; Genotoxicity; Lead poisoning; Neurodevelopment; Neurotoxicity

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; CALCIUM ION; GLUTAMIC ACID; LEAD; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE;

BIOLOGICAL MONITORING; BLOOD BRAIN BARRIER; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL HEALTH; ENZYME ACTIVATION; EXCITOTOXICITY; GENE EXPRESSION REGULATION; GENOTOXICITY; HAIR ANALYSIS; HEALTH HAZARD; HUMAN; LEAD BLOOD LEVEL; LEAD POISONING; NAIL; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; NEUROTOXICITY; NONHUMAN; PRENATAL EXPOSURE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SALIVA ANALYSIS; SISTER CHROMATID EXCHANGE; URINALYSIS;

ANIMALIA;

EID: 65749089509     PISSN: 00487554     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVEH.2009.24.1.15     Document Type: Review

References (200)

1. Agency for Toxic Substances and Disease Registry. Hazardous Substance Release and Health Effects Database (HazDat). Atlanta, GA: Centers for Disease Control and Prevention, 2006. Available at: http://www.atsdr.cdc.gov/hazdat.html
2. Agency for Toxic Substances and Disease Registry. Toxicological profile for lead. Atlanta, GA, USA: US Department of Health and Human Services, Public Health Service, ATSDR, 2006. Available at: hptt://www.atsdr.cdc.gov. Accessed 22 Jan 2009.
3. National Institute of Environmental Health Services. Lead. Research Triangle Park, NC, USA. Available at: http://www.niehs.nih.gov/health/ topics/agents/lead/index.cfm. Last revised 02 Jan 2009.
4. Bornschein RL, Succop PA, Krafft KM, Clark CS, Peace B, Hammond PB. Exterior surface dust lead, interior house dust lead and childhood lead exposure in an urban environment. In: Hemphill D, ed. Trace substances in environmental health. Columbia, MO: University of Missouri, 1986.322-32.
5. Occupational Safety & Health Administration. Lead. 1910.1025. Washington, DC: OSHA, 2006. Available at: http://www.osha.gov/pls/ oshaweb/owadisp.show_document?p_table=STANDARDS&I_id=10030. Accessed 1 December 2006.
6. Occupational Safety & Health Administration. Lead 1926.62. Washington, DC: OSHA, 2006. Available at: http://www.osha.gov/pls/ oshaweb/owadisp.showdocument?p_table=STANDARDS&p_id=10641. Accessed 1 December 2006.
7. Shib R, Hu H, Weisskopf MG, Schwartz BS. Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect 2007;115:483-92.
8. Murata K, Iwata T, Dakeishi M, Karita K. Lead toxicity: does the critical level of lead resulting in adverse effects differ between adults and children? J Occup Health 2009;51:1-12.
9. Lustberg, M; Silbergeld, E. Blood lead levels and mortality. Arch Intern Med 2002;162(21):2443-9
10. Weaver VM, Jaar BG, Schwartz BS, Todd AC, Ahn KD, Lee SS, et al Associations among lead dose biomarkers, uric acid, and renal function in Korean lead workers. Environ Health Perspect 2005;113:36-42.
11. Berlin A, Yodaiken RE, Henman BA. International seminar on the assessment of toxic agents at the workplace. Roles of ambient and biological monitoring. Luxembourg, 8-12 December, 1980; Int Arch Occup Environ Health 1982;50:197-207.
12. DeSilva PE. Determination of lead in plasma and studies of its relationship to lead in erythrocytes. Br J Ind Med 1981;38(3):209-17.
13. Schütz A, Bergdahl IA, Ekholm A, Skerfving S. Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls. Occup Environ Med 1996;53:736-40.
14. Gulson BL, Mizon KJ, Korsch MJ, Horwarth D, Phillips A, Hall J. Impact on blood lead in children and adults following relocation from their source of exposure and contribution of skeletal tissue to blood lead. Bull Environ Contarn Toxicol 1996;56:543-50.
15. Gulson BL, Mahaffey KR, Mizon KP, Korsch MJ, Cameron MA, Vimpani G. Contribution of tissue lead to bone lead in adult female subjects based on stable lead-isotope methods. J Lab Clin Med 1995;125:703-12.
16. Smith DR, Hernandez-Avila M, Tellez Rojo MM, Mercado A, Hu H. The relationship between lead in plasma and whole blood in women. Environ Health Perspect 2002;110:263-8.
17. Barbosa Jr F, Tanus-Santos JE, Gerlach RF, Parsons PJ. A critical review of biomarkers; used for monitoring human exposure to lead: advantages, limitations, and future needs. Environ Health Perspect 2005;113(12)1669-74.
18. Gwiazda R, Campbell C, Smith D. A noninvasive isotopic approach to estimate the bone lead contribution to blood in children: implication for assessing the efficacy of lead abatement. Environ Health Perspect 2005;113:104-10.
19. Roberts JR, Reigart JR, Ebeling M, Hulsey TC. Time required for blood lead levels to decline in nonchelated children. Clin Toxicol 2001;39:153-60.
20. Roy A, Georgopoulos PG, Ouyang M, Freeman N, Lioy PJ. Environmental, dietary, demographic, and activity variables associated with biomarkers of exposure for benzene and lead. J Expo Anal Environ Epidemiol 2003;13(6):417-26
21. Bergdahl IA, Skerfving S. Biomonitoring of lead exposure-alternatives to blood. J Toxicol Environ Health A. 2008;71(18):1235-43.
22. Verseick J, Cornelius R. Trace elements in human plasma and serum. Boca Raton, FL: CRC Press, 1988.
23. Hu H, Rabinowitz M, Smith D. Bone lead as a biological marker in epidemiologic studies of chronic toxicity: conceptual paradigms. Environ Health Perspect 1998;106:1-8.
24. O'Flaherty EJ. Physiologically based models for bone-seeking elements V: lead absorption and disposition in childhood. Toxicol Appl Pharmacol 1995;131:297-308.
25. Landrigan PJ, Todd AC. Direct measurement of lead in bone - a promising biomarker. JAMA 1994;271:239-40.
26. Hernandez-Avila M, Smith D, Meneses F, Sanin LH, Hu H. The influence of bone and blood lead on plasma lead levels in environmentally exposed adults. Environ Health Perspect 1998;106:473-7.
27. Wright RO, Tsaih SW, Schwartz J, Spiro A 3rd, McDonald K, Weiss ST, et al. Lead exposure biomarkers and mini-mental status exam scores in older men. Epidemiology 2003;14(6):713-8.
28. Silbergeld EK. New approaches to monitoring environmental neurotoxins. Annals NY Acad Sci 1993;694:62-71.
29. Omokhodion FO, Crockford GW. Lead in sweat and its relationship to salivary and urinary levels in normal healthy subjects. Sci Total Environ 1991; 103:113-122.
30. Pan AY. Lead levels in saliva and in blood. J Toxicol Environ Health 1981;7:273-80.
31. Thaweboon S, Thaweboon B, Veerapradist W. Lead in saliva and its relationship to blood in the residents of Klity Village in Thailand. Southeast Asian J Trop Med Public Health 2005;36(6): 1576-9.
32. Barbosa F Jr, Corrêa Rodrigues MH, Buzalaf MR, Krug FJ, Gerlach RF, Tanus-Santos JE. Evaluation of the use of salivary lead levels as a surrogate of blood lead or plasma lead levels in lead exposed subjects. Arch Toxicol 2006;80 (10):633-7.
33. Costa de Almeida GR, Umbelino de Freitas C, Barbosa F Jr, Tanus-Santos JE, Gerlach RF. Lead in saliva from lead-exposed and unexposed children. Sci Total Environ 2008;Nov 27. [Epub ahead of print]
34. Tsaih SW, Schwartz J, Lee ML, Amarasiriwardena C, Aro A, Sparrow D, et al. The independent contribution of bone and erythrocyte lead to urinary lead among middle-aged and elderly men: the normative aging study. Environ Health Perspect 1999;107:391-6.
35. Fukui Y, Miki M, Ukai H, Okamoto S, Takada S, Higashikawa K, et al. Urinary lead as a possible surrogate of blood lead among workers occupationally exposed to lead. Int Arch Occup Environ Health 1999;72(8):516-20.
36. Schumacher M, Domingo JL, Llobet JM, Corbella. Lead in children's hair, as related to exposure in Tarragona province, Spain. Sci Total Environ 1991; 104:167-77.
37. Takagi Y, Matsuda S, Imai S, Ohmori Y, Vinson JA, Mehra MC, et al Survey of trace elements in human nails: an international comparison. Bull Environ Contain Toxicol 1988;41:690-5.
38. Nowak B, Chmielnicka J. Relationship of lead and cadmium to essential elements in hair, teeth, and nails and of environmentally exposed people. Ecotoxicol Environ Safe 2000;46(3):265-74.
39. Rodushkin I, Axelsson MD. Application of double focusing sector field ICP-MS for multi-elemental characterization of human hair and nails. Part II: a study of the inhabitants of northern Sweden. Sci Total Environ 2000;262:21-36.
40. Maneakrichten M, Patterson C, Miller G, Settle D, Erel Y. Comparative increases of lead and barium with age in human tooth enamel, rib, and ulna. Sci Total Environ 1991;107:179-203.
41. Cleymaet R, Collys K, Retief DH, Michotte Y, Stop D, Taghon E, et al Relation between lead in surface tooth enamel, blood, and saliva from children residing in the vicinity of a non-ferrous metal plant in Belgium.Br J Ind Med 1991;48(10): 702-9.
42. Fenech M. Cytokinesis-block micronucleus techniques: a detailed description of the method and its application to genotoxicity studies in human populations. Mutat Res 1993;161:193-8.
43. Vaglenov A, Carbonell E, Marcos R. Biomonitoring of workers exposed to lead. Genotoxic effects, its modulation by polyvitamin treatment and evaluation of induced radioresistance. Mutat Res 1998;418:79-92.
44. Wu FY, Chang PW, Wu CC, Kuo HW. Correlations of blood lead with DNA-protein cross-links and sister chromatid exchanges in lead workers. Cancer Epidemiol Biomarkers Prev 2002; 11:287-90,
45. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmun Pharmacol 2006;1(3): 223-36.
46. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005;57(2):173-85.
47. Markovac J, Goldstein GW. Picomolar concentrations of lead stimulate brain protein kinase C. Nature 1988;334:71-73.
48. Bressler JP, Goldstein GW. Mechanisms of lead neurotoxicity. Biochem. Pharmacol 1991;41:479-84.
49. Bressler J, Kim KA, Chakraborti T, Goldstein G. Molecular mechanisms of lead neurotoxicity. Neurochem Res 1999;24(4):595-600.
50. Goldstein GW. Evidence that lead acts as a calcium substitute in second messenger metabolism. NeuroToxicology 1993;14:97-101.
51. Bressler J, Forman S, Goldstein GW. Phospholipid metabolism in neural microvascular endothelial cells after exposure to lead in vitro. Toxicol Appl Pharmacol 1994;126(2):352-60.
52. Finkelstein Y, Markowitz ME, Rosen JF. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res Rev 1998;27(2):168-76.
53. Hwang L. Environmental stressors and violence: lead and polychlorinated biphenyls. Rev Environ Health 2007;22(4):313-28.
54. Centers for Disease Control and Prevention (CDC). Managing elevated blood lead levels among young children: recommendations from the Advisory Committee on Childhood Lead Poisoning Prevention. Atlanta, GA: US Department of Health and Human Services, CDC; 2002.
55. Braga MF, Pereira EF, Albuquerque EX. Nanomolar concentrations of lead inhibit glutamatergic and GABAergic transmission in hippocampal neurons. Brain Res 1999 24;826(1): 22-34.
56. National Research Council. Measuring lead exposure in infants, children, and other sensitive populations. Washington, DC: National Academy Press, 1993.
57. Centers for Disease Control and Prevention (CDC). Preventing lead poisoning in young children. Atlanta, GA: US Department of Health and Human Services, CDC; 1991.
58. Baghurst PA, McMichael AJ, Wigg NR, Vimpani GV, Robertson EF, Roberts RJ, et al Environmental exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study. N Engl J Med 1992;327:1279-84.
59. Birms HJ, Campbell C, Brown MJ; Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention. Interpreting and managing blood lead levels of less than 10 microg/dL in children and reducing childhood exposure to lead: Recommendations of the Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention. Pediatrics 2007;120(5):e1285-98.
60. Roels HA, Hubermont G, Buchet J, Lauwerys Rl. Placental transfer of lead, mercury, cadmium, and carbon monoxide in women: III. Factors influencing the accumulation of heavy metals in the placenta and the relationship between metal concentration in the placenta and in maternal and cord blood. Environ Res 1978;16:236-47.
61. Gardella C. Lead exposure in pregnancy: a review of the literature and argument for routine prenatal screening. Obstet Gynecol Survey 2001;56:231-8.
62. Schell LM, Denham M, Stark AD, Gomez M, Ravenscroft J, Parsons PJ, et al Maternal blood lead concentration, diet during pregnancy, and anthropometry predict neonatal blood lead in a socioeconomically disadvantaged population. Environ Health Perspect 2003;111:195-200.
63. Li PJ, Sheng YZ, Wang QY, Gu LY, Wang YL. Transfer of lead via placenta and breast milk in human. Biomed Environ Sci 2000;13:85-9.
64. Bellinger DC, Needleman HL, Leviton A, Waternaux C, Rabinowitz MB, Nichols ML. Early sensory-motor development and prenatal exposure to lead. Neurobehav Toxicol Teratol 1984;6(5): 387-402.
65. Bellinger D, Leviton A, Needleman HL, Waternaux C, Rabinowitz M. Low-level lead exposure and infant development in the first year. Neurobehav Toxicol Teratol 1986;8(2):151-61.
66. Bellinger D, Leviton A, Waternaux C, Needleman H, Rabinowitz M. Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development. N Engl J Med 1987; 316 (17):1037-43.
67. Hu H, Téllez-Rojo MM, Bellinger D, Smith D, Ettinger AS, Lamadrid-Figueroa H, et al. Fetal lead exposure at each stage of pregnancy as a predictor of infant mental development. Environ Health Perspect 114(11):1730-5.
68. Schnaas L, Rothenberg SJ, Flores MF. Reduced intellectual development in children with prenatal lead exposure. Environ Health Perspect 2006;114 (5):791-7.
69. Rosen JF. Health effects of lead at low exposure levels, Am J Dis Child 1992;146:1278-81.
70. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, et Low-level environmental lead exposure and children's intellectual function: An international pooled analysis. Environ Health Perspect 2005;113(7):894-9.
71. Téllez-Rojo MM, Bellinger DC, Arroyo-Quiroz C, Lamadrid-Figueroa H, Mercado-Garcia A, Schnaas-Arrieta L, et al. Longitudinal associations between blood lead concentrations lower than 10 microg/dL and neurobehavioral development in environmentally exposed children in Mexico City. Pediatrics 118(2):e323-30.
72. Wright JP, Dietrich KN, Ri MD, Hornung RW, Wessel SD, Lanphear BP, et al Association of prenatal and childhood blood lead concentrations with criminal arrests in early adulthood. PLoS Med 2008;5(5):e101.
73. Ziegler EE, Edwards BB, Jensen RL, Mahaffey KR, Fomon SJ. Absorption and retention of lead by infants. Pediatr Res 1978;12(1):29-34.
74. U.S. Environmental Protection Agency (EPA). Estimation of relative bioavailability of lead in soil and soil-like materials using in vivo and in vitro methods. Washington, DC: EPA, 2004.
75. Pounds JG, Marlar RJ, Allen JR. Metabolism of lead-210 in juvenile and adult Rhesus monkeys Macaca mulatta. Bull Environ Contam Toxicol 1978;19:684-91.
76. Aungst BJ, Fung HL. Kinetic characterization of an in vitro lead transport across the rat small intestine. Toxicol Appl Pharmacol 1981;61:38-47.
77. Forbes GB, Reina JC. Effect of age on gastrointestinal absorption (Fe, Sr, lead) in the rat. J Nutr 1972;102:647-52.
78. Kostial K, Kello D, Jugo S, Rabar I, Maljković T. Influence of age on metal metabolism and toxicity. Environ Health Perspect 1978; 25:81-6.
79. Binns HJ, Campbell C, Brown MJ, for the Advisory Committee on Childhood Lead Poisoning Prevention. Interpreting and managing blood lead levels of less than 10 μg/dL in children and reducing childhood exposures to lead. Recommendations of Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention. Pediatrics 2007; 120 (5):e1285-e1298
80. Brown LL, Schneider JS, Lidsky TI. Sensory and cognitive functions of the basal ganglia. Curr Opin Neurobiol 1997;7:157-63.
81. Centers for Disease Control and Prevention (CDC). Preventing lead poisoning in young children. Atlanta, GA: US Department of Health and Human Services CDC, 2005.
82. Carpenter DO. Effects of metals on the nervous system of humans and animals. Int J Occup Med Environ Health 2001;14(3):209-18.
83. American Academy of Pediatrics Committee on Environmental Health. Lead exposure in children: prevention, detection, and management. Pediatrics 2005;116:1036-46.
84. Bellinger DC. Lead. Pediatrics 2004;113:1016-22.
85. Canfield RL, Henderson CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 micrograms per deciliter. N Engl J Med 2003;348:1517-26.
86. Bellinger DC, Needleman HL. Intellectual impairment and blood lead levels. N Engl J Med 2003;349:500-2.
87. Rogan WJ, Ware JH. Exposure to lead in children - how low is low enough? N Engl J Med 2003;348:1515-6.
88. Pocock SJ, Smith M, Baghurst P. Environmental lead and children's intelligence: A systematic review of the epidemiological evidence. Br Med J 1994;309:1189-97.
89. Brody DJ, Pirkle JL, Kramer RA, Flegal KM, Matte TD, Gunter EW, et al Blood levels in the U.S. population. Phase I of the Third National Health and Nutrition Examination Survey (NHANES III, 1988 to 1991). JAMA 1994;272: 277-83.
90. Tang HW, Yan HL, Hu XH, Leang YX, Shen XY. Lead cytotoxicity in primary cultured rat astrocytes and Schwann cells. J Appl Toxicol 1996;16: 187-96.
91. Trope I, Lopez-Villegas D, Lenkinski RE. Magnetic resonance imaging and spectroscopy of regional brain structure in a 10-year-old boy with elevated blood lead levels. Pediatrics 1998;101(6):E7.
92. Sciarillo WG, Alexander G, Farrell KP. Lead exposure and child behavior. Am J Pub Health 1992;82:1356-60.
93. Mendelsohn AL, Dreyer BP, Fierman AH, Rosen CM, Legano LA, Kruger HA. Low-level lead exposure and behavior in early childhood. Pediatrics 1998;101(3):E10.
94. Needleman HL. History of lead poisoning in the world. In: George AM, ed. Lead Poisoning Prevention and treatment: Implementing a National Program in Developing Countries. Proc. of the International Conference on Lead Poisoning Prevention and Treatment. February 8-10, 1999, Banglore, India;17-25. Available at http://www.leadpoison.net/general/ history.htm. Accessed 17 January 2009.
95. Monnet-Tschudi F, Zurich M-G, Boschat C, Corbaz A, Honegger P. Involvement of environmental mercury and lead in the etiology of neurodegenerative diseases. Rev Environ Health 2006;21(2):105-17.
96. Weisskopf MG, Proctor SP, Wright RO, Schwartz J, Spiro A 3rd, Sparrow D, et al. Cumulative lead exposure and cognitive performance among elderly men. Epidemiology 2007;18(1):59-66.
97. Bleecker ML, Ford DP, Lindgren KN, Hoese VM, Walsh KS; et al. Differential effects of lead exposure on components of verbal memory. Occup Environ Med. 2005;62(3):181-7.
98. Stokes L, Letz R, Gerr F, Kolczak M, McNeil FE, Chettle DR, et al Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience. Occup Environ Med 1998;55: 507-16.
99. White RF, Diamond R, Proctor S, Morey C, Hu H. Residual cognitive deficits 50 years after lead poisoning during childhood. Br J Ind Med 1993; 50:613-22.
100. Tonge JI, Burry AF, Saal JR. Cerebellar calcification: a possible marker of lead poisoning. Pathology 1977;9(4):289-300.
101. Reyes PF, Gonzalez CF, Zalewska MK, Besarab A. Intracranial calcification in adults with chronic lead exposure. AJR Am J Roentgenol 1986;146 (2):267-70.
102. Schroter C, Schroter H, and Huffman G. Neurologic and psychiatric manifestations of lead poisoning in adults. Fortschr Neurol Psychiat 1991;59(10):413-24.
103. Jones B. Schizophrenia: Into the next millennium. Can J Psychiat 1993;38(3):567-9.
104. Opler MG, Buka SL, Groeger J, McKeague I, Wei C, Factor-Litvak P, et al. Prenatal exposure to lead, delta-aminolevulinic acid, and schizophrenia: further evidence. Environ Health Perspect 2008; 116(11):1586-90.
105. Rice DC. Lead-induced behavioral impairment on a spatial discrimination reversal task in monkeys during different periods of development. Appl Pharmacol 1990;106:327-33.
106. Rice DC. Lead-induced changes in learning: evidence for behavioral mechanisms from experimental animal studies. Neurotoxicology 1993;14: 167-78.
107. Rice DC. Effect of lead on schedule-controlled behavior in monkeys. In: Seiden LS, Balster RL, eds. Behavioral Pharmacology: The Current Status, New York, NY, USA: Alan R. Liss, 1985; 473-86.
108. Rice DC. Behavioral effects of lead in monkeys tested during infancy and adulthood, Neurotoxicol Teratol 1992;14:235-45.
109. Schneider JS, Lee MH, Anderson DW, Zuck L, Lidksy TI. Enriched environment during development is protective against lead-induced neurotoxicity. Brain Res 2001;896:48-55.
110. Van Praag H, Schneida AF, Christie BR, Toni N, Palmer TD, Gage FH. Functional neurogenesis in the adult hippocampus. Nature 2002;415(6875): 1030-4.
111. Pabello NG, Bolivar VJ. Young brains on lead: adult neurological consequences. Toxicol Sci 2005; 86 (2):211-13.
112. Dabrowska-Bouta B, Sulkowski G, Bartosz G, Walski M, Rafalowska U. Chronic lead intoxication affects the myelin membrane status in the central nervous system (CNS) of adult rats. J Mol Neurosci 1999;13:127-39.
113. Ruan SY, Gu Z-w, Toxic effects of lead on the blood brain barrier in rats. J Occup Health 1999; 41:39-42.
114. Ruan S, Gu Z, Yang Y. [Energy dispersive X-ray analysis in studying the permeability of blood-brain barrier caused by lead in rats] Zhonghua Yu Fang Yi Xue Za Zhi. 1999;33(2):107-9.
115. Wang Q, Luo W, Zheng W, Liu Y, Xu H, Zheng G, et al. Iron supplement prevents lead-induced disruption of the blood-brain barrier during rat development. Toxicol Appl Pharmacol 2007;15: 219(1):33-41.
116. Struzynska L; Walski M; Gadamski R; Dabrowska-Bouta B; Rafalowska U. Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity. Molec Chem Neuropathol 1997;31(3):207-24.
117. Fox DA, Campbell ML, Blocker YS. Functional alterations and apoptotic cell death in the retina following developmental or adult lead exposure. Neurotoxicology 1997;18:645-54.
118. He L, Poblenz AT, Medrano CJ, Fox DA. Lead and calcium produce rod photoreceptor cell apoptosis by opening the mitochondrial permeability transition pore. J Biol Chem 2000;275: 12175-84.
119. Khan D, Qayyum S, Saleem S, Khan F. Lead-induced oxidative stress adversely affects health of the occupational workers. Toxicol Ind Health 2008;24(9):611-8.
120. Ye XB, Fu H, Zhu JL, Ni WM, Lu YW, Kuang XY, et al A study on oxidative stress in lead-exposed workers. J Toxicol Environ Health A. 1999;11;57(3):161-72.
121. Ding Y, Gonick HC, Vaziri ND. Lead promotes hydroxyl radical generation and lipid peroxidation in cultured aortic endothelial cells. Am J Hypertens 2000;13(5 Pt 1):552-5.
122. Antonio-García MT, Massó-Gonzalez EL. Toxic effects of perinatal lead exposure on the brain of rats: involvement of oxidative stress and the beneficial role of antioxidants. Food Chem Toxicol. 2008;46(6):2089-95.
123. Patrick L. Mechanisms of lead toxicity: The effect of lead on oxidant/ antioxidant balance. Altern Med Rev 2006;11(2)114-26.
124. Anderson AC, Pueschel SM, Linakis JG. Pathophysiology of lead poisoning. In: Pueschel SM, Linakis JG, Anderson AC, eds. Lead poisoning in children. Baltimore, MD: P.H. Brookes; 1996;75-96.
125. Lidsky TI, Schneider JS. Lead neurotoxicity in children: basic mechanisms and clinical correlates. Brain 2003;126(1):5-19.
126. Beal MF, Brouillet E, Jenkins BG, Ferrante JG, Kowall NW, Miller JM, et al Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993;13:4181-92.
127. Arundine M, Tymianski M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 2003;34(4-5):325-37.
128. Riedel G, Platt B, Micheau J. Glutamate receptor function in learning and memory. Behav Brain Res 2003;140(1-2):1-47.
129. Dringen R, Pawlowski PG, Hirrlinger J. Peroxide detoxification by brain cells. J Neurosci Res 2005; 79:157-65.
130. Gilley J, Coffer PJ, Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 2003;162:613-22.
131. Droge, W. Free radicals in the physiological control of cell function. Physiol Rev 2002;82:47-95.
132. Dong GJ, Zhao ZY, Zhu ZW. [Effects of lead exposure on nitric oxide synthase activity in different brain regions of developmental rat] Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2003 Aug;21(4):263-5.
133. Emerit J, Edeas M, Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 2004;58(1):39-46.
134. Michaelis EK. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 1998;54:369-415.
135. Tiffany-Castiglioni E, Sierra EM, Wu JN, Rowles TK. Lead toxicity in neuroglia. Neurotoxicology 1989;10:417-43.
136. Tiffany-Castiglioni E, Qian Y. Atroglia as metal depots: molecular mechanisms for metal accumulation, storage and release. NeuroToxicology 2001; 22(5):577-592
137. Lindahl LS, Bird L, Legare ME, Mikeska G, Bratton GR, Tiffany-Castiglioni E. Differential ability of astroglia and neuronal cells to accumulate lead: dependence on cell type and on degree of differentiation. Toxicol Sci 1999;50: 236-43.
138. Holtzman D, Olson JE, DeVries C, Bensch K. Lead toxicity in primary cultured cerebral astrocytes and cerebellar granular neurons. Toxicol Appl Pharmacol 1987;89:211-25.
139. Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes in rat brain. Brain Res 1979;161:303-10.
140. Gebhart AM, Goldstein GW. Use of an in vitro system to study the effects of lead on astrocyte-endothelial cell interactions: a model for studying toxic injury to the blood-brain barrier. Toxicol Appl Pharmacol 1988;94(2):191-206.
141. Goldstein GW. Developmental neurobiology of lead toxicity. In: Needlmann HL, ed. Human lead exposure, Boca Raton, FL: CRC, 1992;191-208.
142. Dave V, Vitarella D, Aschner JL, Fletcher P, Kimelberg HK, Aschner M. Lead increases inositol 1,4,5-triphosphate levels but does not interfere with calcium transients in primary rat astrocytes Brain Res 1993;618:9-18.
143. Bradbury MW, Deane R. Permeability of the blood-brain barrier to lead. Neurotoxicology 1993; 14:131-6.
144. Kerper LE, Hinkle PM. Lead uptake in brain capillary endothelial cells: activation by calcium store depletion. Toxicol Appl Pharmacol 1997; 146:127-33.
145. Kerper LE, Hinkle PM. Cellular uptake of lead is activated by depletion of intracellular calcium stores. J Biol Chem 1997;272:8346-52.
146. White LD, Cory-Slechta DA, Gilbert ME, Tiffany-Castiglioni E, Zawia NH, Virgolini M, et al. New and evolving concepts in the neurotoxicology of lead. Toxicol Appl Pharmacol 200715; 225(1):1-27.
147. Shi LZ, Zheng W. Early lead exposure increases the leakage of the blood-cerebrospinal fluid barrier in vitro. Hum Exp Toxicol 2007;26(3): 159-67.
148. Suszkiw JB. Presynaptic disruption of transmitter release by lead. Neurotoxicology. 2004;25(4):599-604.
149. Cory-Slechta DA. Relationships between lead-induced learning impairments and changes in dopaminergic, cholinergic, and glutamatergic neurotransmitter system functions. Ann Rev Pharmacol Toxicol 1995;35:391-415.
150. Zhu ZW, Yang RL, Dong GJ, Zhao ZY. Study on the neurotoxic effects of low-level lead exposure in rats. J Zhejiang Univ Sci B 2005;6(7):686-92.
151. NewtonAC. Protein Kinase C: Structure, function, and regulation. JBC 1995;270(48)28495-8.
152. Matthies HJG, Palfrey HC, Himing LD, Miller RJ. Down regulation of protein kinase C in neuronal cells: effects on neurotransmitter release. J Neurosci 1987;7:1198-206.
153. Weiss S, Ellis J, Hendly DD, Lenox RH. Translocation and activation of protein kinase C in striatal neurons in primary culture: relationship to phorphol dibutyrate actions on the inositol phosphate generating system and neurotransmitter release. J Neurochem 1989;52:530-6.
154. Akers RF, Lovinger DM, Colley D, Linden D, Routenberg A. Translocation of protein kinase C activity after LTP may mediate hippocampal synaptic plasticity. 1986;Science 231:587-9.
155. Routtenberg A. A tale of two contingent protein kinase C activators: both neutral and acidic lipids regulate synaptic plasticity and information storage. Prog Brain Res 1991;89:249-61.
156. Shearman MS, Sekiguchi K, Nishizuka Y. Modulation of ion channel activity: a key function of the protein kinase C enzyme family. Pharmacol Rev 1989;41:211-47.
157. Laterra J, Bressler JP, Indurti RR, Belloni-Olivi L, Goldstein GW. Inhibition of astroglia-induced endothelial differentiation by inorganic lead: a role for protein kinase C. Proc Natl Acad Sci USA 1992;89:10748-52.
158. Chon HH, Ma T, Ho IK. Protein kinase C in rat brain is altered by developmental lead exposure. Neurochem Res 1999.24:415-21.
159. Wehner JM, Sleight S, Upchurch M. Hippocampal protein kinase C activity is reduced in poor spatial learners. Brain Res 1990;523:181-7.
160. Pascale A, Govoni S, Battaini F. Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples. Mol Neurobiol 1998;16:49-62.
161. Birnbaum SG, Yuan PX, Wang M, Vijayraghavan S, Bloom AK, Davis DJ, et al. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 2004;306(5697):882-4
162. Hwang KY, Lee BK, Bressler JP, Bolla KI, Stewart WF, Schwartz BS. Protein kinase C activity and the relations between blood lead and neurobehavioral function in lead workers. Environ Health Perspect 2002;110(2):133-8.
163. Wang FS, Liu ZH, Zhang JS, Di JR. [Effects of lead exposure on protein kinase C and calmodulin expression in hippocampus and neurobehavioral function of baby rats] Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2008;26(3):139-42. In Chinese.
164. Guilarte TR, McGlothan JL. Hippocampal NMDA receptor mRNA undergoes subunit specific changes during developmental lead exposure. Brain Res 1998;790(1-2):98-107
165. Chang W, Xie H, Chen X.[Effect of prenatal lead exposure on the gene transcription and protein expression level of POU-domain protein Brn-3a in different regions of offspring rat brain] Wei Sheng Yan Jiu 2008;37(4):385-8. In Chinese.
166. Song B, Han CC, Sun X, Peng L, Niu YJ. [Effects of prenatal exposure to low level, lead on learning and memory of rats' offspring] Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2006; 24(7):399-402. In Chinese.
167. Yin J, Niu YJ, Zhang R, Song B, Cheng JX. [Effects of prenatal exposure to low level lead on expression of GAP-43 in hippocampus of rat's offspring] Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2008;26(4):208-11. In Chinese.
168. Liu MY, Hsieh WC, Yang BC. In vitro aberrant gene expression as the indicator of lead-induced neurotoxicity in U-373MG cells. Toxicol 2007; 147(1):59-64.
169. Reddy GR, Zawia NH. Lead exposure alters Egr-1 DNA-binding in the neonatal rat brain. Int J Dev Neurosci 2000;18:791-5.
170. Hitzfeld B, Taylor DM. Characteristics of lead adaptation in a rat kidney cell line. I. Uptake and subcellular and subnuclear distribution of lead. Mol Toxicol 1989;2:151-62.
171. Hanas JS, Rodgers JS, Bantle JA, Cheng YG. Lead inhibition of DNA-binding mechanism of Cys2His2 zinc finger proteins. Mol Pharmacol 1999;56:982-988.
172. Zawia NH, Sharan R, Brydie M, Oyama T, Crumpton T. Sp1 as a target site for metal-induced perturbations of transcriptional regulation of developmental brain gene expression. Brain Res Dev Brain Res 1998;107:291-8.
173. Crumpton T, Atkins DS, Zawia NH, and Barone Jr S. lead, inorganic. In: Spencer PS, Schaumburg HH, Ludolph AC, eds. Experimental and clinical neurotoxicology. 2nd edition. New York: Oxford University Press; 2000;708-20.
174. Onalaja AO, Claudio L. Genetic susceptibility to lead poisoning. Environ Health Perspect 2000;108 (1):23-28.
175. Bellinger D, Dietrich KN. Low-level lead exposure and cognitive function in children. Pediatr Ann 1994;23:600-5.
176. Rajan P, Kelsey KT, Schwartz JD, Bellinger DC, Weuve J, Sparrow D, et al. Lead burden and psychiatric symptoms and the modifying influence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism: the VA Normative Aging Study. Am J Epidemiol 2007;166(12):1400-8.
177. Cheng Y, Willett WC, Schwartz J, Sparrow D, Weiss S, Hu H. Relation of nutrition to bone lead and blood lead levels in middle-aged to elderly men. The Normative Aging Study. Am J Epidemiol 1998;147:1162-74.
178. Schwartz BS, Lee BK, Lee GS, Stewart WF, Simon D, Kelsey K, et al Associations of blood lead, dimercaptosuccinic acid-chelatable lead and tibia lead with polymorphisms in the vitamin D receptor and [delta]-aminolevulinic acid dehydrase genes. Environ Health Perspect 2000;108:949-54.
179. Zelikoff JT, Li JH, Ahartwig A, Wang XW, Costa M, Rossman TG. Genetic toxicology of lead compounds. Carcinogenesis 1988;9:1727-32.
180. Winder C, Bonin T. The genotoxicity of lead. Mutat Res 1993;285:117-24.
181. Mäki-Paakkanen J, Sorsa M, Vainio H. Chromosome aberrations and sister chromatid exchanges in lead-exposed workers. Hereditas 1981;94:269-75.
182. Bulsma JB, De France HF. 1976. Cytogenetic investigations in volunteers ingesting inorganic lead. Int Arch Occup Environ Health 28:145-8.
183. O'Riordan ML, Evans HJ, 1974. Absence of significant chromosome damage in males occupationally exposed to lead. Nature 247: 50-53.
184. Bauchinger H, Dresp J, Schmid E, Englert N, Krause C. Chromosome analyses of children after ecological lead exposure. Mutat Res 1977;56:75-80.
185. Dalprà L, Tibiletti MG, Nocera G, Giulotto P, Auriti L, Carnelli V, et al SCE analysis in children exposed to lead emission from a smelting plant. Mutat Res 1983;120:249-56.
186. Wu FY, Chang PW, Wu CC, Kuo HW. Correlations of blood lead with DNA-protein cross-links and sister chromatid exchanges in lead workers. Cancer Epidemiol Biomarkers Prev 2002; 11:287-90.
187. Duydu Y, Süzen HS, Aydin A, Cander O, Uysal H, Işimer A, et al. Correlation between lead exposure indicators and sister chromatid exchange (SCE) frequencies in lymphocytes from inorganic lead exposed workers. Arch Environ Contam Toxicol 2001;41(2):241-6.
188. Danadevi K, Rozati R, Saleha Banu B, Hanumanth Rao P, Grover P. DNA damage in workers exposed to lead using comet assay. Toxicology 2003;187:183-93.
189. Steinmetz-Beck A, Szahidewicz-Krupska E, Beck B, Poreba R, Andrzejak R. Genotoxicity effect of chronic lead exposure assessed using the comet assay] Med Pr 2005;56(4):295-302. In Polish.
190. Fracasso ME, Perbellini L, Soldà S, Talamini G, Franceschetti P. Lead induced DNA strand breaks in lymphocytes of exposed workers: Role of reactive oxygen species and protein kinase C. Mutat Res 2002;515:159-69.
191. Vaglenov A, Carbonell E, Marcos R. Biomonitoring of workers exposed to lead. Genotoxic effects, its modulation by polyvitamin treatment and evaluation of induced radioresistance. Mutat Res 1998;418:79-92.
192. Vaglenov A, Creus A, Laltchev S, Petkova V, Pavlova S, Marcos R. Occupational exposure to lead and induction of genetic damage. Environ Health Perspect 2001;109(3):295-8.
193. Chen Z, Lou J, Chen S, Zheng W, Wu W, Jin L, et al. Evaluating the genotoxic effects of workers exposed to lead using micronucleus assay, comet assay and TCR gene mutation test. Toxicology 2006;223(3):219-26.
194. Mielzyńska D, Siwińska E, Kapka L, Szyfter K, Knudsen LE, Merlo DF. The influence of environmental exposure to complex mixtures including PAHs and lead on genotoxic effects in children living in Upper Silesia, Poland. Mutagenesis 2006;21(5):295-304.
195. Hartwig A, Schlepegrell I, Beyersmann D. Indirect mechanism of lead induced genotoxicity in cultured mammalian cells. Mutat Res 1990;241: 75-82.
196. Poma A, Pittaluga E, Tucci A. Lead acetate genotoxicity on human melanoma cells in vitro. Melanoma Res 2003;13(6):563-566.
197. Valverde M, Fortoul TI, Diaz-Barriga F, Mejia J, Rojas del Castillo E. Genotoxicity induced in CD-1 mice by inhaled lead: differential organ response. Mutagen 2002;17(1):55-61.
198. Gebhart E, Rossman T. Mutagenicity, carcinogenicity, teratogenicity. VCH Verlagsgesellschaft, Weinheim, Germany, 1991.
199. Johonsor, FM. The genetic effect of environmental lead. Mutat Res 1998;410:123-40.
200. Kašuba V, Rozgaj R, Fuči' A, Varnai VM, Piasek M. Lead acetate genotoxicity in suckling rats. Biologia Bratislava 2004;59/ 6:779-85.